Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP Botanical Advisory Panel Will Address Non-Monograph Standards

This article was originally published in The Tan Sheet

Executive Summary

A new U.S. Pharmacopeia advisory panel will seek to set standards on a range of topics not covered in USP's botanical monographs, such as optimal standards for the growth, handling and harvesting of botanical ingredients

You may also be interested in...



Nature’s Resource Labeling To Spell Out ABCs Of Supplement Information

Pharmavite and the American Botanical Council are teaming up to develop new labeling for the Nature's Resource line of supplements, the groups announced at the National Association of Chain Drug Stores Marketplace 2002 in San Diego June 16-18

USP Quality Demonstration Program "Supplements" Monograph Development

The U.S. Pharmacopeia's new draft proposal, Quality Demonstration Program for Dietary Supplements, will complement the group's ongoing monograph development.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel